SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
05-Apr-24 4:30 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 03-Apr-24 | Private Sale (Planned) | 10,451 | $4.95 | $51,732.40 | (100%) 10.45K to 0 | |
02-Apr-24 4:58 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 02-Apr-24 | Planned Option Sale | 150 | $4.98 | $747.04 | (1%) 10.6K to 10.45K | |
02-Apr-24 4:58 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Apr-24 | Payment of Exercise | 4,732 | $5.12 | $24,227.80 | (31%) 15.33K to 10.6K | |
02-Apr-24 4:58 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Mar-24 | Option Exercise | 15,333 | -- | -- | 100% 0 to 15.33K | |
14-Dec-23 4:24 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 12-Dec-23 | Private Sale (Planned) | 6,287 | $4.95 | $31,120.60 | (100%) 6.29K to 0 | |
08-Dec-23 4:23 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 06-Dec-23 | Private Sale (Planned) | 6,287 | $3.95 | $24,833.70 | (50%) 12.57K to 6.29K | |
02-Nov-23 4:52 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Nov-23 | Payment of Exercise | 6,301 | $2.22 | $13,988.20 | (33%) 18.88K to 12.57K | |
02-Nov-23 4:52 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Oct-23 | Option Exercise | 18,875 | -- | -- | 100% 0 to 18.88K | |
02-Aug-23 4:21 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Jul-23 | Private Sale (Planned) | 7,348 | $3.95 | $29,024.60 | (100%) 7.35K to 0 | |
04-Apr-23 6:56 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 03-Apr-23 | Payment of Exercise | 623 | $2.58 | $1,607.34 | (8%) 7.97K to 7.35K | |
04-Apr-23 6:56 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 31-Mar-23 | Option Exercise | 2,000 | -- | -- | 33% 5.97K to 7.97K | |
04-Apr-22 5:03 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 01-Apr-22 | Payment of Exercise | 27,281 | $1.12 | $30,554.70 | (31%) 87.0K to 59.72K | |
14-Feb-19 5:18 PM View: | Syros Pharmaceuticals, Inc. (SYRS) | 12-Feb-19 | Grant | 87,000 | -- | -- | 100% 0 to 87.0K |